A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
NCT06767540
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
198
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Placebo
DRUG:
placebo
Sponsor
Akeso